These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9371997)

  • 1. Erythropoietin in the treatment of anemia in chronic infectious, inflammatory, and malignant diseases.
    Means RT
    Curr Opin Hematol; 1995 May; 2(3):210-3. PubMed ID: 9371997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human erythropoietin in cancer-related anemia. Review of clinical evidence.
    Crawford J
    Oncology (Williston Park); 2002 Sep; 16(9 Suppl 10):41-53. PubMed ID: 12380954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum erythropoietin levels in elderly inpatients with anemia of chronic disorders and iron deficiency anemia.
    Joosten E; Van Hove L; Lesaffre E; Goossens W; Dereymaeker L; Van Goethem G; Pelemans W
    J Am Geriatr Soc; 1993 Dec; 41(12):1301-4. PubMed ID: 8227911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin: mechanisms of action and indications for treatment.
    Vreugdenhil G; Frenken LA; Koene RA
    Neth J Med; 1993 Jun; 42(5-6):187-202. PubMed ID: 8377877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of the anemia of chronic renal failure with recombinant human erythropoietin.
    Adamson JW; Eschbach JW
    Annu Rev Med; 1990; 41():349-60. PubMed ID: 2184735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of human recombinant erythropoietin in oncologic surgery].
    Mercuriali F
    Tumori; 1997; 83(4 Suppl 2):S16-9. PubMed ID: 9487379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical application of recombinant erythropoietin in anemic cancer patients.
    Henry DH
    Hematol Oncol Clin North Am; 1994 Oct; 8(5):961-73. PubMed ID: 7852218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy.
    Case DC; Bukowski RM; Carey RW; Fishkin EH; Henry DH; Jacobson RJ; Jones SE; Keller AM; Kugler JW; Nichols CR
    J Natl Cancer Inst; 1993 May; 85(10):801-6. PubMed ID: 8487324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of iron in optimizing responses of anemic cancer patients to erythropoietin.
    Glaspy J; Cavill I
    Oncology (Williston Park); 1999 Apr; 13(4):461-73; discussion 477-8, 483-8. PubMed ID: 10234700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anemia of primary autonomic failure and its reversal with recombinant erythropoietin.
    Biaggioni I; Robertson D; Krantz S; Jones M; Haile V
    Ann Intern Med; 1994 Aug; 121(3):181-6. PubMed ID: 8017744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease.
    Schreiber S; Howaldt S; Schnoor M; Nikolaus S; Bauditz J; Gasché C; Lochs H; Raedler A
    N Engl J Med; 1996 Mar; 334(10):619-23. PubMed ID: 8592524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy.
    Ludwig H; Sundal E; Pecherstorfer M; Leitgeb C; Bauernhofer T; Beinhauer A; Samonigg H; Kappeler AW; Fritz E
    Cancer; 1995 Dec; 76(11):2319-29. PubMed ID: 8635038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin and the anemia of chronic diseases.
    De Marchi S; Pirisi M; Ferraccioli GF
    Clin Exp Rheumatol; 1993; 11(4):429-44. PubMed ID: 8403591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of recombinant erythropoietin during the preoperative period].
    Janssens M; Lamy M
    Ann Fr Anesth Reanim; 1995; 14 Suppl 1():98-106. PubMed ID: 7486323
    [No Abstract]   [Full Text] [Related]  

  • 15. Erythropoietin hyporesponsiveness: from iron deficiency to iron overload.
    Tarng DC; Huang TP; Chen TW; Yang WC
    Kidney Int Suppl; 1999 Mar; 69():S107-18. PubMed ID: 10084294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human erythropoietin treatment of anemic cancer patients.
    Henry DH
    Cancer Pract; 1996; 4(4):180-4. PubMed ID: 8900758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human erythropoietin in the treatment of anemic patients with hematological malignancies.
    Kasper C
    Ann Hematol; 2001 Jun; 80(6):319-29. PubMed ID: 11475144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anemia of chronic disease: spectrum of associated diseases in a series of unselected hospitalized patients.
    Cash JM; Sears DA
    Am J Med; 1989 Dec; 87(6):638-44. PubMed ID: 2589399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin for the treatment of anemia associated with hematological malignancy.
    Littlewood TJ
    Hematol Oncol; 2001 Mar; 19(1):19-30. PubMed ID: 11276043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
    Phair JP; Abels RI; McNeill MV; Sullivan DJ
    Arch Intern Med; 1993 Dec; 153(23):2669-75. PubMed ID: 8250662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.